Category: Disclosures

[Disclosure] Jusung Engineering (036930) – Setting of Record Date or Period for Closure of Shareholders’ Register / 2024-08-16

August 16, 2024August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Jusung Engineering set September 2, 2024, as the record date to determine eligible voting shareholders for its upcoming 2024 Extraordinary General Meeting of Shareholders. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Record Date for Voting Rights…

Disclosures, Semiconductors

[Disclosure] Jusung Engineering (036930) – Resolution on Convocation of General Meeting of Shareholders (Extraordinary General Meeting) / 2024-08-16

August 16, 2024August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Jusung Engineering resolved to convene an Extraordinary General Meeting of Shareholders on October 8, 2024, to vote on the spin-off plan approval and outside director appointment. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Agenda Submission and…

Semiconductors, Disclosures

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-08-14

August 14, 2024August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The company will hold a conference call IR session sponsored by Macquarie Securities for major overseas institutional investors to review Q2 2024 earnings, discuss the H2 outlook, and share progress on establishing its position in HBM and advanced package bonding markets. 📊 [Key Disclosure Contents &…

Semiconductors, Disclosures

[Disclosure] Hana Micron (067310) – Additional Listing (Public Offering of Forfeited Shares After Shareholder Rights Offering) / 2024-08-14

August 14, 2024August 2, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hana Micron disclosed the additional listing of 5,000,000 common shares issued through a rights offering with general public offering of forfeited shares, scheduled for listing on August 20, 2024. 📊 Key Disclosure Content & Financial Figures Summary 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of…

Semiconductors, Disclosures

[Disclosure] SK Square (402340) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

August 14, 2024July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square held an Extraordinary General Meeting of Shareholders on August 14, 2024, and approved the agenda to appoint President Myung Jin Han as a new executive director for a 3-year term as originally proposed. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key…

Semiconductors, Disclosures

[Disclosure] SK Square (402340) – Change of CEO (Representative Executive Officer) / 2024-08-14

August 14, 2024July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square has appointed President Myung Jin Han as its new CEO following the resignation of former CEO Seong Ha Park, effective August 14, 2024. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Confirmation of Executive Leadership Transition via Periodic…

Semiconductors, Disclosures

[Disclosure] Hanwha Aerospace (012450) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

August 14, 2024August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace approved Agenda Item No. 1, “Approval of Spin-off Plan,” as originally proposed at its Extraordinary General Meeting of Shareholders. 📊 [Key Disclosure Details & Summary of Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring Spin-off Execution and Subsequent Listing Process With the approval…

Disclosures, Defense

[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-08-14

August 14, 2024August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics announced a disclosure correction following a favorable first-instance ruling by the Seoul Administrative Court, which ruled to revoke the administrative dispositions imposed by the Securities and Futures Commission and the Financial Services Commission in 2018. 📊 [Key Disclosure Details & Summary Statistics] 📝 Editor’s…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-08-14

August 14, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that the U.S. Food and Drug Administration (FDA) has approved its global Phase 3 clinical trial plan for CT-P55 to evaluate efficacy and safety compared with Cosentyx in patients with plaque psoriasis. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up…

Disclosures, Bio & Healthcare

[Disclosure] Jusung Engineering (036930) – (Correction) Sales and Supply Contract / 2024-08-14

August 14, 2024August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The completion date for Jusung Engineering’s KRW 19.4B semiconductor equipment supply contract with SK Hynix for China has been adjusted to August 20, 2024, due to delivery schedule changes. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of…

Semiconductors, Disclosures